Table I.
Proposed Metrics for Endpoints
| Existing Recommendations | YearA |
|---|---|
| Antiplatelet and Statin at time of Discharge for all Symptomatic PAD [7,13,17,18] | 2007 |
| Surveillance of Patency at 1-year after Intervention for Patients with Claudication [7] | 2015 |
| Zero 30-day Major Amputation Rate after Intervention for Claudication [13] | 2015 |
|
| |
| Existing Recommendations without Clear Threshold | |
|
| |
| Low to Zero 30-day Mortality Rate after Intervention for Claudication [7,13,17] | 2007 |
| High Amputation Free Survival and Survival at 1-year after Intervention for Patients with Claudication [7,13] | 2013 |
|
| |
| Potential Endpoints | |
|
| |
| 30-day Major Amputation and MACE Rates after Intervention for CLI [8] | 2009 |
| Amputation Free Survival and Survival at 1-year after Intervention for Patients with CLI [8] | 2009 |
| Surgical Site Infection Rates Stratified by Symptom Status | |
|
| |
| Endpoints of Unknown Significance | |
|
| |
| Threshold for Blood Transfusion | |
A
Year represents earliest year of publication for a guideline or supporting evidence